|
WDR44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.731000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.229600E-01 |
| Normal-vs-Stage2 |
8.884000E-01 |
| Normal-vs-Stage3 |
2.548000E-01 |
| Normal-vs-Stage4 |
1.685600E-01 |
| Stage1-vs-Stage2 |
8.169200E-01 |
| Stage1-vs-Stage3 |
4.493800E-01 |
| Stage1-vs-Stage4 |
2.670000E-01 |
| Stage2-vs-Stage3 |
4.968400E-01 |
| Stage2-vs-Stage4 |
3.699400E-01 |
| Stage3-vs-Stage4 |
8.250800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.267800E-01 |
| Normal-vs-AfricanAmerican |
8.246100E-02 |
| Normal-vs-Asian |
2.760400E-01 |
| Caucasian-vs-AfricanAmerican |
2.507600E-01 |
| Caucasian-vs-Asian |
3.156400E-01 |
| AfricanAmerican-vs-Asian |
1.087220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.330200E-01 |
| Normal-vs-Female |
5.169400E-01 |
| Male-vs-Female |
6.139800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.907800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.529000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.325800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.305960E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.345800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.963400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.838200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.572400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.833500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.353900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.650400E-01 |
| Normal-vs-Grade 2 |
7.769600E-01 |
| Normal-vs-Grade 3 |
3.037600E-02 |
| Normal-vs-Grade 4 |
7.774100E-02 |
| Grade 1-vs-Grade 2 |
3.824400E-01 |
| Grade 1-vs-Grade 3 |
3.344300E-02 |
| Grade 1-vs-Grade 4 |
1.123570E-01 |
| Grade 2-vs-Grade 3 |
9.722100E-03 |
| Grade 2-vs-Grade 4 |
6.280200E-02 |
| Grade 3-vs-Grade 4 |
7.414400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.917200E-01 |
| Normal-vs-ccB subtype |
3.919400E-01 |
| ccA subtype-vs-ccB subtype |
2.902000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.492800E-01 |
| Normal-vs-N1 |
7.999000E-01 |
| N0-vs-N1 |
9.409400E-01 |
|
|
